Celularity Inc. (CELU)
NASDAQ: CELU · IEX Real-Time Price · USD
2.860
-0.160 (-5.30%)
Jul 22, 2024, 11:13 AM EDT - Market open
Celularity Employees
Celularity had 225 employees as of December 31, 2022. The number of employees did not change compared to the previous year.
Employees
225
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$65,724
Profits / Employee
-$806,258
Market Cap
65.13M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 225 | 0 | - |
Dec 31, 2021 | 225 | 63 | 38.89% |
Dec 31, 2020 | 162 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Burning Rock Biotech | 786 |
Prenetics Global | 324 |
Pro-Dex | 146 |
BioLineRx | 79 |
Eyenovia | 57 |
VSee Lab/iDoc Virtual Telehealth Solutions, Inc. | 40 |
Entera Bio | 18 |
Milestone Scientific | 17 |
CELU News
- 7 weeks ago - Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 2 months ago - Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing - GlobeNewsWire
- 2 months ago - Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy - GlobeNewsWire
- 3 months ago - Celularity Inc. to Host Investor and Analyst Research & Development Day - GlobeNewsWire
- 3 months ago - Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing - GlobeNewsWire
- 3 months ago - Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024 - GlobeNewsWire
- 3 months ago - Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products - GlobeNewsWire
- 3 months ago - Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental Cells - GlobeNewsWire